Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
1255 daily bars · split adjusted
Current price $171.99
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 19, 26 | JP Morgan | maintain | Overweight | Overweight |
| Oct 15, 26 | Barclays | maintain | Overweight | Overweight |
| Oct 14, 26 | Morgan Stanley | maintain | Overweight | Overweight |
| Oct 12, 26 | Truist Securities | upgrade | Hold | Buy |
| Oct 8, 26 | Goldman Sachs | maintain | Buy | Buy |
| Sep 30, 26 | Piper Sandler | maintain | Overweight | Overweight |
| Sep 28, 26 | Keybanc | upgrade | Underweight | Sector Weight |
| Sep 22, 26 | GLJ Research | maintain | Buy | Buy |
| Aug 27, 26 | BMO Capital | upgrade | Market Perform | Outperform |
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 39.10 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 19.52 | Oscillator | Buy |
| Williams %R (14) | -82.52 | Oscillator | Buy |
| MACD (12, 26, 9) | -5.72 (Hist 0.50) | Oscillator | Buy |
| Average Directional Index (14) | 23.74 (+DI 14.7 / -DI 23.6) | Trend | Sell |
| EMA 20 | 178.71 | MA | Strong Sell |
| SMA 20 | 176.28 | MA | Sell |
| EMA 50 | 191.36 | MA | Strong Sell |
| SMA 50 | 193.28 | MA | Strong Sell |
| SMA 200 | 217.57 | MA | Strong Sell |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Sep 30, 26 | Ahearn Michael J | director | A-Award | 422 | — |
| Sep 30, 26 | Post William J | director | A-Award | 300 | — |
| Sep 30, 26 | Stebbins Paul H | director | A-Award | 300 | — |
| Sep 30, 26 | Sweeney Michael T | director | A-Award | 300 | — |
| Sep 30, 26 | George Anita M. | director | A-Award | 300 | — |
| Sep 30, 26 | Kro Lisa A | director | A-Award | 300 | — |
| Sep 30, 26 | Wright Norman L. | director | A-Award | 300 | — |
| Sep 30, 26 | Renduchintala Venkata S M | director | A-Award | 300 | — |
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| SC 13G/A | Oct 15, 2026 | 2026-10-15 16:56:27 | View |
| SC 13G | Oct 15, 2026 | 2026-10-15 07:43:45 | View |
| 4 | Oct 2, 2026 | 2026-10-02 18:50:29 | View |
| 4 | Oct 2, 2026 | 2026-10-02 18:47:31 | View |
| 4 | Oct 2, 2026 | 2026-10-02 18:40:49 | View |
| 4 | Oct 2, 2026 | 2026-10-02 18:35:56 | View |
| 4 | Oct 2, 2026 | 2026-10-02 18:27:49 | View |
| 4 | Oct 2, 2026 | 2026-10-02 18:24:39 | View |
| 4 | Oct 2, 2026 | 2026-10-02 18:22:00 | View |
| 4 | Oct 2, 2026 | 2026-10-02 18:19:07 | View |
Proxy statement (DEF 14A) disclosures
Annual filings (FY) with consensus forward estimates (hatched)
Stock news · updated daily
In the latest trading session, First Solar (FSLR) closed at $171.25, marking a -2.04% move from the previous day.
First Solar (FSLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Recently, Zacks.com users have been paying close attention to First Solar (FSLR). This makes it worthwhile to examine what the stock has in store.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 30, 2026 | 2.90 | 3.92 | Beat 35.2% | $1.06B |
| Apr 30, 2026 | 3.03 | 3.22 | Beat 6.3% | $1.04B |
| Feb 24, 2026 | 5.14 | 4.84 | Miss -5.8% | $1.68B |
| Oct 30, 2025 | 4.24 | 4.24 | Beat 0.0% | $1.59B |
| Jul 31, 2025 | 2.66 | 3.18 | Beat 19.5% | $1.10B |
| Apr 29, 2025 | 2.49 | 1.95 | Miss -21.7% | $844.6M |
TTM vs. 5-year historical average (annual ratios)
| Metric | FSLR | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 10.6x | -58.1x · sector 14.8x | Discount |
| Forward P/E (FY26E) | 9.8x | EPS est. 17.52 | In line |
| Price / Book | 1.8x | 2.5x | Discount |
| Price / Sales | 3.4x | 4.9x | Discount |
| EV / EBITDA | 7.0x | 19.2x | Discount |
| Return on equity | 18.0% | — | Healthy |
| Gross margin | 44.0% | 30.3% | Above hist. |
| Debt / Equity | 0.02 | 0.07 | Conservative |
| Piotroski / Altman Z | 8/9 | Z 5.55 | Safe zone |
Discounted cash flow model